{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21236 Intellectual property policy 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ":Document Title:"
                    },
                    {
                        "text": "INTELLECTUAL PROPERTY POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21236"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "13 December 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Intellectual, property"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "Treasury Guidance on Knowledge Assets April 2021"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "17"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Corporate: Commercial"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Margaret Hathaway"
                    },
                    {
                        "text": "Programme Director Commercial"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Group Clinical Strategy Board"
                    },
                    {
                        "text": "09 December 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Jonathan Dunk"
                    },
                    {
                        "text": "Chief Commercial Officer"
                    },
                    {
                        "text": "23 November 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "January 2022"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21236 Intellectual property policy 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Jonathan Dunk"
                    },
                    {
                        "text": "Chief Commercial Officer"
                    },
                    {
                        "text": "18 November 2021"
                    },
                    {
                        "text": "Charlotte Williams"
                    },
                    {
                        "text": "Chief Strategy and Improvement Officer"
                    },
                    {
                        "text": "18 November 2021"
                    },
                    {
                        "text": "Erica White"
                    },
                    {
                        "text": "Programme Director, Innovation and Entrepreneurship"
                    },
                    {
                        "text": "18 November 2021"
                    },
                    {
                        "text": "Ashley Solieri"
                    },
                    {
                        "text": "Group Head of Research"
                    },
                    {
                        "text": "18 November 2021"
                    },
                    {
                        "text": "Tony Young"
                    },
                    {
                        "text": "National Clinical Lead for Innovation NHS England and NHS Improvement"
                    },
                    {
                        "text": "18 November 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Group Clinical Strategy Board"
                    },
                    {
                        "text": "09 December 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) MSEPO-20234 Health records policy MSEPO-21040 Data security and protection toolkit audit policy MSEPO-20233 Conflicts of interest policy Consent policy or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Margaret Hathaway"
                    },
                    {
                        "text": "Newly created MSE policy which replaces the following documents at Broomfield Hospital: 09069"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": "RA02 Intellectual property protection and exploitation policy."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and Responsibilities within the Trust .................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Invisible value ............................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Application .................................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Ownership .................................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Protection ..................................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Evaluation ..................................................................................................................... 9  Share the benefits......................................................................................................... 9  The Trust's name .......................................................................................................... 9  Records and administration ........................................................................................ 10  Ownership and commercial benefit of intellectual property ......................................... 10  What happens to revenue the Trust receives from IP? ............................................... 11  Copyright .................................................................................................................... 11  Who and what does this policy cover .......................................................................... 12  Students and other non-employees at the Trust ......................................................... 12  What if the Trust is not interestede in my IP ............................................................... 13  Ownership disputes .................................................................................................... 13  Ownership obligations ................................................................................................ 13  Training requirements ................................................................................................. 14  Monitoring and audit ................................................................................................... 14  Approval and implementation ..................................................................................... 14  Equality impact assessment ....................................................................................... 14  References ................................................................................................................. 15 Appendix 1: Preliminary equality analysis .......................................................................... 16"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This policy is to promote the use of research results and other knowledge generated within the Trust to benefit a wider community, and if possible to obtain a commercial benefit to the Trust in doing so."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "This policy applies to all staff that are full or part-time employees of the Trust where the intellectual property (IP) generated relates to their area of employment by the Trust whether it was created in the course of a working day or outside normal working hours and/or away from the place of work."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The NHS recognises the need to develop as an organisation which has innovation at the core of its business, developing new products and service innovations for better health care delivery. Innovation occurs naturally in the normal course of employment at all levels throughout the NHS. The innovation may be a novel treatment, device, new drug, data, software, training material or a new management system."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Innovation can be defined as new inventions, processes and ways of working. In recent guidance from HM Governance (Knowledge Assets in Government. April 2021) the term Knowledge Assets has been introduced as information an organisation holds, the skills and expertise of its staff and even its reputation. Knowledge assets often arise from innovation programmes and are critical to the effective operation of any organisation. Most innovations are best implemented by making them freely available through normal knowledge management processes once they have demonstrated a quantifiable health service gain. However, some innovations can only be realised through commercial development; for these innovations, professional management of the associated Intellectual Property (IP) is crucial. The NHS recognises that the protection of IP should facilitate rather than impede the uptake of innovations with commercial potential."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "All of these considerations made it desirable for the Trust to develop this policy, which outlines how the Trust with the aid of specialist organisations within the NHS will protect and manage the IP created by its employees for the improvement of healthcare while ensuring that any revenue generated is shared with the employees creating the IP."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.6,
                "text": "IP generated from any source is now recognised by the NHS as an asset of value which should be managed in the best interests of NHS patients, employees and society as a whole."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.7,
                "text": "Trusts have the power to generate income through commercial exploitation of IP and the Health and Social Care Act enables Trusts, subject to the approval of a business case, to take a shareholding in spin-out companies set up as a vehicle to exploit IP provided that it does not interfere with its functions or obligations under NHS contracts."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.8,
                "text": "Income generated by successful commercial exploitation of IP arising from the Trust will be retained by the Trust and shared with inventors."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This policy sets out guidance on who owns Intellectual Property and how any commercial benefit is shared between the Trust and the inventors."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.2,
                "text": "This policy only applies when the innovation or knowledge asset has been generated by an employee of the trust during the ordinary course of their job."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Intellectual property is the novel or previously un-described tangible output of intellectual and creative activity. IP can arise in the form of ideas, inventions, discoveries, software, research material, know-how and expertise, designs and images. Like physical property, it can be bought, sold or licensed to others."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Intellectual property rights (IPR) are rights which are protected by law and which enable the owner to control the IP and be rewarded for its use, encouraging further innovation."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The main intellectual property rights are:"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Patents (for inventions, covering for example new diagnostic equipment or surgical tools, new drugs, and new processes and equipment). Patents must be registered to be effective. Publication of results before seeking patent protection may be fatal to the protection of the invention. An invention must not be obvious development, compared to what is already known to someone who is experienced in the relevant field."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where there is a possibility of patent protection being obtained this should be reported to the Trust's IP Lead as soon as possible."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Copyright (for written works, drawings, photographs, sound recordings, and works such as computer software and collections of data, written or computer based protocols, forms). Copyright arises automatically in most cases. However, it is desirable to ensure that documents or other works which may be covered by copyright contain appropriate notices, such as:"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u201c\u00a9 [Name] NHS Trust 20[12]. All rights reserved. Not to be reproduced in whole or in part without the permission of the copyright owner.\u201d"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Designs (covering the shape and configuration of articles, such as equipment and tools). Designs can be protected both without registration and by registration. If there is the possibility of design protection advice should be sought from the Trust's IP Lead."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Confidentiality (which can apply to any information). Confidential information or \"Know-how\" is information which may be commercially or"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "technically valuable and which is regarded as secret. It may, for example, include information on industrial processes or be a list of clients Confidentiality is generally protected by written agreements. In all cases, the \"know-how\" will only retain its value if it is managed effectively. All exploitation partners, business partners and collaborators should be bound by conditions of confidentiality through a Confidential Disclosure Agreement (CDA). Such an agreement should only be signed by an appropriate, authorised representative of the Trust, so that the risk from disclosure can be assessed and suitable records kept."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Trade names such as the Trust name and brands used by the Trust."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Innovation Working Group: The Innovation Working Group will provide the Forum for capturing innovative ideas and identify whether there is a commercial benefit and potential to generate Intellectual Policy"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Investment Group: The Investment Group is responsible for approving any innovation schemes which may result in the generation of Intellectual Property"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Finance Committee: In line with SFIs the Finance Committee and/or the Trust Board are responsible for agreeing the commercial arrangements and any split of revenue generating from Intellectual Property"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Chief Executive: The Chief Executive as the Accounting Officer has overall responsibility for the quality and safety of services provided by the Trust. In this respect, he/she is responsible for ensuring that the infrastructure required to support the delivery and implementation of this document is available. He/she will delegate the full implementation of this document to a relevant Executive Director."
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Medical Officer: The Chief Medical Officer is responsible for ensuring that the necessary systems, processes, training and competency assessment (where appropriate) are available to ensure that all medical and dental staff are able to comply with the contents of this document. In addition, he/she is responsible for ensuring that the monitoring and audit of this document is undertaken and reported in the appropriate forum as indicated in the document."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Nursing and Quality Officer: The Chief Nursing and Quality Officer is responsible for ensuring that the necessary systems, processes, training and competency assessment (where appropriate) are available to ensure that all non- medical staff (nurses, midwives and allied health professionals) are able to comply with the contents of this document."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Strategy and Improvement Officer: The Chief Strategy and Improvement Officer will be responsible for ensuring there are systems and processes in place to encourage innovation and capture innovative ideas that may generate Intellectual Property."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Chief Commercial Officer: The Chief Commercial Officer will act as the IP lead and is responsible for ensuring that there are systems and processes in place to communicate and implement this document in the clinical areas and will support the Chief Strategy and Improvement Officer when innovative idea generate a commercial benefit and generation of intellectual property"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Deputy Chief Executive and Managing Directors: The Deputy Chief Executive and Managing Directors are responsible for ensuring that systems and processes are in place throughout the Divisions to ensure that this document is disseminated appropriately and that monitoring of compliance is undertaken, with remedial action implemented as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Invisible value"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "The Trust generates valuable information and potential intellectual property in many of its activities. The aim of the Trust is to promote wide and effective use of such information and ideas generated within the Trust, if possible with a commercial return to the Trust which it can reinvest in its activities. Moreover, to identify valuable information and rights, to secure appropriate protection, and to promote use; and to educate those involved in the value and opportunities which may arise."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Application"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Patents, trademarks and copyrights provide the basis for protecting intellectual property generated from new ideas and developments: from new drugs or methods of diagnosis, to papers, manuals and forms; from software and collections of data to new procedures. It arises from research, but also in day to day activities in the Trust. Examples are rights in inventions, copyright in papers, books, or collections of information and data and in software, rights in designs, and trade and brand names used by the Trust."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Ownership"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "In general, intellectual property rights generated by those working in the Trust in the course of their work, belongs to the Trust. In relation to some types of work, such as academic books, the Trust may transfer its rights to the person involved."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "In some cases there will be contractual arrangements under which the arising intellectual property belongs to a third party. Normally, unless a third party in the private sector meets the full cost of any research or development, the Trust will expect to retain an interest in the intellectual property. Staff should ensure they are familiar with any relevant third party contract, so as to meet any requirements in relation to reporting and protection of intellectual property."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "All those working in the Trust should consider whether any developments, ideas or results they or their colleagues generate or information or data they collect could be used to benefit others, especially outside the Trust. If so they should review this with the person to whom they report, or the Trust's IP Lead."
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Protection"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "If such material is potentially valuable, those in the Trust should ensure that they report this, with appropriate details, to the person they report to, or to the Trust's IP Lead, so that appropriate steps can be taken to protect any relevant intellectual property. Until appropriate protection is obtained, those who know of the material should  avoid  doing  anything  which  might damage  its  value  (and in  particular disclosing information without protection), as long as this can be achieved while doing their job."
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Publication and dissemination of relevant ideas and information is important. However, unless the appropriate steps are taken in advance, disclosure to others outside the Trust may invalidate any protection. Staff involved should therefore not disclose information to anyone outside the Trust without considering whether it is valuable or disclosure could be damaging to the Trust, and if so, permitting the Trust to put in place appropriate protection. This may be in the form of confidentiality agreements, or copyright notices, or in suitable cases, patent protection. If in doubt you should consult the person to whom you report or the Trust's IP Lead."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Evaluation"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The Trust's Chief Commercial Officer will act as IP Lead and will consider, in conjunction with you, the value of the material, what steps can be taken to promote the wider beneficial use of any material, and whether commercial exploitation is appropriate; what steps are appropriate to take to protect the material. The Trust's IP Lead may review this with a panel of advisors."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "If appropriate the Trust's IP Lead will advise on what steps should be taken to promote wider dissemination, and/or prepare a plan to implement suitable exploitation, and will report the conclusions to you. The Trust will not normally be willing to undertake significant risks in the course of commercial exploitation, and where this is possible, the Trust will look to a third party to assume such risks."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Sharing the benefits"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "If revenue arises for the Trust from exploitation of any material, after accounting for any costs it has incurred the Trust will share a part of the benefit with you in accordance with the current revenue sharing policy."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Those involved should provide such assistance as the Trust's IP Lead requests to help protect and permit exploitation of relevant material. In some cases they may be required to sign documents relating to rights in the material."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.3,
                "text": "If the Trust concludes that it is not appropriate for it to be involved in exploitation, unless there are reasonable grounds for it not doing so, it will allow you to take steps to exploit the results yourself. The Trust may need to maintain some control, in order to protect its interests or the interests of patients."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "The Trust's name"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The Trust's name and brands are valuable assets of the Trust. It is important that they are not damaged by inappropriate use, and at the same time that the Trust can be promoted by use of its name in the right circumstances. Any use of the Trust's name in relation to any publication or other publicity should be cleared with the Trust's IP Lead in advance, and advice obtained on how the name may be used."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Records and administration"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "The Trust will maintain an administrative procedure for handling the matters set out above, and will maintain records of developments, ideas, and other information reported under this policy. In addition, so far as relevant, the Trust will implement the terms of this policy in contracts of employment for staff and in relation to research and other contracts with third parties."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Ownership and commercial benefit of intellectual property"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Generally, if a member of staff (an employee) of the Trust creates or generates any intellectual property, including inventions and information and results in the course of performing their duties, the rights in that intellectual property belong to the Trust (subject to some statutory exceptions)."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "In addition, if any other person working for or within the Trust creates or generates intellectual property while working for the Trust, the normal rule which the Trust will apply is that rights belong to the Trust. This is intended to apply to consultants, visiting research students and other categories of non-employed staff. In practice, in each case the position is also likely to be affected by the contract under which the work is being carried out, or relevant research contracts."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "In each case this includes activities carried out wholly or partly under Trust auspices. It also includes activities using Trust facilities, and work carried out during time for which the member of staff receives financial reward or remission of duties or responsibilities from or through the Trust; for example where they are given time off to write a book."
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "In any case it may also be important that the Trust own the rights as the Trust may have entered obligations with third parties in relation to the intellectual property rights. It is important that the rights initially belong to the Trust so that it can comply with those obligations."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "In cases where the intellectual property does not belong to the Trust, but has been generated by use of or access to Trust resources, this must not be exploited without prior written consent from the Trust. The Trust will not unreasonably withhold consent but may, in its discretion require a reasonable reward reflecting the contribution made from its resources."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "What happens to revenue the Trust receives from IP?"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "To encourage staff to contribute to the generation of IP, the Trust operates a reward scheme for staff creating or generating IP which subsequently becomes commercialised. Revenue generated will be shared with the Trust and the inventor according to the Trust's revenue sharing policy with the table below being used as a guide. Any particular aspects regarding the commercial value will be taken into account when finalising the revenue sharing ratio. The shared revenue will be net of any protection and exploitation costs incurred by or on behalf of the Trust."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "type": "table",
            "sequence_num": 82,
            "data": {
                "num_rows": 5,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Net revenue"
                    },
                    {
                        "text": "Inventor(s)"
                    },
                    {
                        "text": "Department"
                    },
                    {
                        "text": "Trust"
                    },
                    {
                        "text": "First \u00a310K"
                    },
                    {
                        "text": "80%"
                    },
                    {
                        "text": "10%"
                    },
                    {
                        "text": "10%"
                    },
                    {
                        "text": "Next \u00a340K"
                    },
                    {
                        "text": "75%"
                    },
                    {
                        "text": "12.5%"
                    },
                    {
                        "text": "12.5%"
                    },
                    {
                        "text": "Next \u00a3200K"
                    },
                    {
                        "text": "50%"
                    },
                    {
                        "text": "25%"
                    },
                    {
                        "text": "25%"
                    },
                    {
                        "text": "Over \u00a3250K"
                    },
                    {
                        "text": "35%"
                    },
                    {
                        "text": "32.5%"
                    },
                    {
                        "text": "32.5%"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "In cases where there are a number of inventors the income allocated will be divided between them. In all cases the shared revenue will be net of any protection and exploitation costs incurred by or on behalf of the Trust."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Copyright"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Although copyright of any work produced by an employee in the course of normal employment belongs to the Trust, the Trust will normally grant to the author a royalty free licence to the copyright of any work published in a recognised scientific, technical, professional or management journal or book and will not claim a share of any income derived from such works. The Trust will not grant such a licence for materials created by a member of staff during the course of and related to their employment, which are on the following non-exhaustive list:"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Course or training materials"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient information"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Software programmes"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Designs, specification or other works which may be necessary to protect rights in commercially exploitable intellectual property."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "The Trust will respect the moral rights of its employees as authors in copyright materials if asserted by notification to the Research and Development Lead, with the exception to any materials related to computer programs, the design of a typeface or any computer generated work \u2013 in standing with the Copyright, Designs and Patents Act 1988."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Who and what does this policy cover?"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "All staff that are full or part-time employees of the Trust where the IP generated relates to their area of employment by the Trust whether it was created the course of a working day or outside normal working hours and/or away from the place of work."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Staff with contracts of employment with the Trust whose payroll costs are partially or fully funded by another party (e.g. medical charity, Government Department) unless the contract between the Trust and that party gives ownership of the IP to that party."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "Staff employed part-time by the Trust who are self-employed or otherwise employed part-time. Where IP is generated during the non-Trust employment but involves use of or access to Trust resources then 5.5 above will apply."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "Trust staff seconded to another organisation or employees of another organisation hosted by the Trust under contract subject to the terms defined in the contract between the Trust and that organisation."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.5,
                "text": "Independent providers of services who generate IP from research funded by the NHS are required to inform the Trust and share the benefits of its commercialisation. Where IP is assigned to the Trust, the independent service provider will benefit under the revenue sharing scheme of the Trust."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.6,
                "text": "Collaborative projects - if work/research is conducted by a Trust employee in partnership with another organisation, a formal agreement setting out ownership (or sharing) of generated IP is required. The Research and Development Lead will have primary responsibility for agreeing IP sharing agreements with collaborating institutions."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Students and other non-employees at the Trust"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Students, where they are not employees of the Trust, are required to sign a confidentiality agreement which provides that the student disclose details of any inventions to the Trust and assign the rights to the Trust on request. Similar provisions will apply to other researchers at the Trust who are neither staff nor students e.g. Senior Research Fellows and other emeritus staff."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "What if the Trust isn't interested in my IP?"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "When IP is generated, and the Trust chooses not to further the development or commercial exploitation of such IP for whatever reason, the IP will be assigned to the inventor on request who may wish to pursue its further development independently."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Ownership disputes"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "If the ownership of IP is disputed, dated written records relating to the IP in question will be assessed by the Trust with professional help to establish the ownership of the IP, the inventor(s) and their proportionate contribution as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Employees' obligations"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "From time to time an employee may generate IP which may have value in the delivery of better patient care. All employees who may have created any form of intellectual property are required to bring it to the immediate attention of the Trust IP Lead who will provide first level advice and engage the services of outside advisors as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "Disclosure to persons outside of the Trust (other than under explicit terms of confidentiality) may invalidate any subsequent attempt to gain IP rights and significantly diminish both potential commercial value and benefits accruing to both the Trust and the inventor. It is essential therefore that all ideas and developments are not generally discussed and are reported instead through the correct channels."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.3,
                "text": "All employees should treat as confidential and not disclose to any third party any research results or other confidential information relating to IP developments without prior written approval of the Trust's IP Lead. If there is any uncertainty as to the sensitivity or confidentiality of the information, the employee should consult with the Trust IP Lead prior to any disclosure."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.4,
                "text": "Employees must not, under any circumstances, disclose before protection, sell, assign, licence, give or otherwise trade in IP without the Trust's written agreement."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "How will the Trust manage IP?"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Any employee wishing to discuss the protection of any idea or other form of intellectual property should inform the IP Lead at the earliest opportunity and, in any event, before disclosure of the idea (whether orally or in writing) to any party outside the Trust."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "The IP Lead will be the initial contact point for advice, and can provide details of the support available for the management of IP."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "The Trust is the vehicle for holding patents and other intellectual property, but is free at its absolute discretion to engage another party (e.g. an independent company) to exploit its intellectual property on its behalf."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "The Trust will take steps to promote understanding by those working in the Trust of the issues arising under this policy, in particular the value and protection for intellectual property, and how to identify this."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "The Trust may employ an auditing process to identify and evaluate IP and otherwise assist in its commercialisation."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.2,
                "text": "The Trust's IP Lead will maintain an administrative procedure for handling the matters set out above, and will maintain records of developments, ideas, and other information reported under this policy. In addition, so far as relevant, the Trust will implement the terms of this policy in contracts of employment for staff, and in relation to research and other contracts with third parties."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "All policies, procedures and guidelines will be approved by Group Clinical Strategy Board which is the specialist group with the authority to approve local (Author just type over this text) guidelines. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "It is the author's responsibility to inform the Innovation Working Group of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Treasury Guidance on Knowledge Assets April 2021"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Intellectual property policy / MSEPO-21236 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Intellectual property policy / MSEPO-21236 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Intellectual property policy/MSEPO-21236 (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "type": "table",
            "sequence_num": 131,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 132,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Review site based policies and align across the MSE group"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "MSE standardisation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Consistency for all staff across MSE group"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No, combination of existing policies."
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes; Consultation with key individuals as detailed. Further consultation will be required as policy is reviewed as the Trusts Innovation and Commercial Strategies are developed"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 133,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Margaret Hathaway"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Programme Director, Commercial"
                    },
                    {
                        "text": "18 November 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 134
        }
    ]
}